Literature DB >> 20537753

Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.

Oliviero Riggio1, Lorenzo Ridola, Stefania Angeloni, Federica Cerini, Chiara Pasquale, Adolfo Francesco Attili, Fabrizio Fanelli, Manuela Merli, Filippo Maria Salvatori.   

Abstract

BACKGROUND & AIMS: The incidence of post-TIPS hepatic encephalopathy (HE) could be reduced by using stents with a small diameter. The aim of this study was to compare the incidence of HE and the clinical efficacy of TIPS created with 8- or 10-mm PTFE-covered stents.
METHODS: Consecutive cirrhotics submitted to TIPS for variceal bleeding or refractory ascites were randomized to receive a 8- or 10-mm covered stent. As recommended by our Ethical Committee, the trial was stopped after the inclusion of 45 patients.
RESULTS: The two groups were comparable for age, sex, etiology, and psychometric performance. After TIPS, the portosystemic pressure gradient was significantly higher in the 8-mm stent group (8.9+/-2.7 versus 6.5+/-2.7 mmHg; p=0.007). Consequently, the probability of remaining free of complications due to portal hypertension was significantly higher in the 10-mm than in the 8-mm stent group: 82.9% versus 41.9% at one year; log-rank test, p=0.002. In particular, the persistence of ascites with the need for repeated paracentesis was significantly more frequent in the patients treated with 8-mm stent diameter for refractory ascites (log-rank test, p=0.008). The probability of remaining free of HE was similar in both groups. Cumulative survival rate was similar in both groups.
CONCLUSIONS: The use of 8-mm diameter stents for TIPS leads to a significantly less efficient control of complications of portal hypertension. HE remains an unsolved major problem after TIPS. Copyright 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20537753     DOI: 10.1016/j.jhep.2010.02.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  32 in total

1.  Clinical application value of preoperative selective partial splenic embolization before splenectomy plus portal-azygous disconnection.

Authors:  Shengxing Zhu; Sheng Chang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients.

Authors:  Nathan E Frenk; Teodora Bochnakova; Suvranu Ganguli; Nathaniel Mercaldo; Andrew S Allegretti; Daniel S Pratt; Kei Yamada
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

3.  Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Silvia Nardelli; Stefania Gioia; Chiara Pasquale; Ilaria Pentassuglio; Alessio Farcomeni; Manuela Merli; Filippo Maria Salvatori; Leandra Nikolli; Sabrina Torrisi; Francesca Greco; Valeria Nicoletti; Oliviero Riggio
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

4.  No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Oliviero Riggio; Silvia Nardelli; Chiara Pasquale; Ilaria Pentassuglio; Stefania Gioia; Eugenia Onori; Camilla Frieri; Filippo Maria Salvatori; Manuela Merli
Journal:  Metab Brain Dis       Date:  2015-08-20       Impact factor: 3.584

Review 5.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.

Authors:  Xing-Shun Qi; Ming Bai; Zhi-Ping Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

6.  Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jian-Bo Zhao; Chao Feng; Qiao-Hua Zhu; Xiao-Feng He; Yan-Hao Li; Yong Chen
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 7.  Clinical management of type C hepatic encephalopathy.

Authors:  Lorenzo Ridola; Oliviero Riggio; Stefania Gioia; Jessica Faccioli; Silvia Nardelli
Journal:  United European Gastroenterol J       Date:  2020-02-26       Impact factor: 4.623

8.  Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension.

Authors:  Sara Santos; Eduardo Dantas; Filipe Veloso Gomes; José Hugo Luz; Nuno Vasco Costa; Tiago Bilhim; Filipe Calinas; Américo Martins; Élia Coimbra
Journal:  GE Port J Gastroenterol       Date:  2020-06-09

9.  Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.

Authors:  Barbara Geeroms; Wim Laleman; Annouschka Laenen; Sam Heye; Chris Verslype; Schalk van der Merwe; Frederik Nevens; Geert Maleux
Journal:  Eur Radiol       Date:  2016-09-15       Impact factor: 5.315

10.  Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation.

Authors:  Jiacheng Liu; Jinqiang Ma; Chen Zhou; Chongtu Yang; Songjiang Huang; Qin Shi; Bin Xiong
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.